A new drug Mebron was tried in 46 patients with acute and chronic inflammation of the ear, nose and throat and in 33 postoperative cases, obtaining significant data that the drug has a potent effect in improving local swelling and pains. The authors judged the drug as effective for inflammatory diseases of the upper respiratory system.
